THE Department of Health recently reported the case of a patient who was severely ill with a new strain of A(H1N1) influenza (swine flu) and died despite being promptly treated with the antiviral drug oseltamivir, which is sold under the trade name Tamiflu.
The case will be investigated to determine if the patient died because the virus was resistant to the drug. One way or another, however, the patient’s death should serve as a reminder that Tamiflu is not a panacea.
On Aug. 21, the WHO issued guidelines for the use of antivirals in the treatment of patients infected with the A(H1N1) pandemic virus. The document stated that most patients infected with the virus experienced typical influenza symptoms and recovered fully within a week, even without medical treatment. That being the case, healthy patients who fall ill but do not suffer complications need not be treated with antiviral drugs.
For severely ill patients and those whose condition begins to deteriorate, the WHO recommends treatment with oseltamivir as soon as possible, preferably within 48 hours after serious symptoms appear.
Dangerous symptoms listed include shortness of breath or difficulty breathing, turning blue, bloody sputum, chest pain, high fever persisting beyond three days and low blood pressure.
Among A(H1N1) patients, treatment with oseltamivir can alleviate symptoms and speed up recovery, just as with seasonal influenza patients. While some experts consider it best to administer the medicine to all confirmed A(H1N1) patients within 48 hours, the WHO guidelines recommend that antivirals only be given if patients exhibit severe symptoms. This recommendation is probably based on concern that overuse of the drug will greatly increase the possibility of drug-resistant virus strains appearing.
The WHO’s Aug. 21 update on this year’s H1N1 pandemic says that the health body had been notified of 12 cases of oseltamivir-resistant strains worldwide. These were all isolated cases arising from mutations in the virus, and there were no apparent epidemiological links between them, nor is there any evidence of onward transmission from these cases.
Even so, several oseltamivir-resistant strains of seasonal H1N1 influenza have appeared over the past few years. Since none of the drug-resistant strains that have been isolated are highly infectious, they do not pose a significant risk to public health security. Since the new, pandemic influenza strain is an H1N1 variant, it would not be surprising if drug-resistant strains were to arise as a result of nonessential use of oseltamivir.
In Taiwan, regulations on the use of oseltamivir have been relaxed, making it likely that cases of resistance to the drug will occur. The danger is that a highly infectious, drug-resistant strain of the pandemic virus may appear and spread rapidly. In that case, it would be necessary to treat patients with the other known effective antiviral drug, zanamivir (trade name Relenza), instead.
Liou Pei-pai is a former director of the Taiwan Animal Health Research Institute.
TRANSLATED BY JULIAN CLEGG
China badly misread Japan. It sought to intimidate Tokyo into silence on Taiwan. Instead, it has achieved the opposite by hardening Japanese resolve. By trying to bludgeon a major power like Japan into accepting its “red lines” — above all on Taiwan — China laid bare the raw coercive logic of compellence now driving its foreign policy toward Asian states. From the Taiwan Strait and the East and South China Seas to the Himalayan frontier, Beijing has increasingly relied on economic warfare, diplomatic intimidation and military pressure to bend neighbors to its will. Confident in its growing power, China appeared to believe
After more than three weeks since the Honduran elections took place, its National Electoral Council finally certified the new president of Honduras. During the campaign, the two leading contenders, Nasry Asfura and Salvador Nasralla, who according to the council were separated by 27,026 votes in the final tally, promised to restore diplomatic ties with Taiwan if elected. Nasralla refused to accept the result and said that he would challenge all the irregularities in court. However, with formal recognition from the US and rapid acknowledgment from key regional governments, including Argentina and Panama, a reversal of the results appears institutionally and politically
In 2009, Taiwan Semiconductor Manufacturing Co (TSMC) made a welcome move to offer in-house contracts to all outsourced employees. It was a step forward for labor relations and the enterprise facing long-standing issues around outsourcing. TSMC founder Morris Chang (張忠謀) once said: “Anything that goes against basic values and principles must be reformed regardless of the cost — on this, there can be no compromise.” The quote is a testament to a core belief of the company’s culture: Injustices must be faced head-on and set right. If TSMC can be clear on its convictions, then should the Ministry of Education
The Chinese People’s Liberation Army (PLA) provided several reasons for military drills it conducted in five zones around Taiwan on Monday and yesterday. The first was as a warning to “Taiwanese independence forces” to cease and desist. This is a consistent line from the Chinese authorities. The second was that the drills were aimed at “deterrence” of outside military intervention. Monday’s announcement of the drills was the first time that Beijing has publicly used the second reason for conducting such drills. The Chinese Communist Party (CCP) leadership is clearly rattled by “external forces” apparently consolidating around an intention to intervene. The targets of
RSS